LOC441258 Inhibitors
The term LOC441258 Inhibitors designates a specific class of chemical compounds engineered to modulate the activity of LOC441258, a molecular target currently under scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC441258 within cellular processes. The structural features of LOC441258 Inhibitors undergo a rigorous optimization process, including computational modeling and structure-activity relationship studies, to ensure the precision of their molecular configurations for effective binding to the target.
The significance of LOC441258 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC441258, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC441258 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC441258 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC441258 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC441258 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus may inhibit mTOR, a kinase involved in cell cycle progression and protein synthesis, potentially leading to reduced expression of proteins like the speedy/RINGO family member E9. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, potentially reducing the expression of proteins including speedy/RINGO family member E9. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C alkylates DNA, which can lead to DNA damage and potentially inhibit the transcription of various genes, including those coding for cell cycle regulators. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
As an analog of uracil, 5-Fluorouracil is incorporated into RNA instead of uridine, disrupting RNA processing and function, which could reduce the expression of proteins such as speedy/RINGO family member E9. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA, disrupting the function of topoisomerase II and hindering RNA and DNA synthesis, which could impact the expression of cell cycle-related proteins. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, causing DNA strand breaks and potentially affecting the transcription of genes involved in cell cycle regulation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin targets DNA topoisomerase I, preventing the relegation of single-strand DNA breaks and influencing transcription of genes including those related to cell cycle control. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is a dihydrofolate reductase inhibitor, leading to a decrease in thymidine and purine synthesis, which are necessary for DNA and RNA synthesis, and could potentially impact the expression of cell cycle proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, which may lead to an accumulation of regulatory proteins that inhibit the cell cycle, thus potentially decreasing the necessity for proteins like the speedy/RINGO family member E9. | ||||||
Chlorambucil | 305-03-3 | sc-204682 sc-204682A | 250 mg 1 g | $52.00 $122.00 | 3 | |
Chlorambucil alkylates DNA, leading to cross-linking and ultimately interfering with DNA replication and transcription, which could affect the expression of cell cycle regulators. | ||||||